Skip to main content

Y35 Pill: purple, capsule/oblong, 14mm

The pill with imprint Y35 (Purple, Capsule/Oblong, 14mm) has been identified as Lamotrigine Extended-Release 250 mg and is used for Bipolar Disorder, Lennox-Gastaut Syndrome, Seizure Prevention, Epilepsy, and Seizures. It belongs to the drug class triazine anticonvulsants and is not a controlled substance.

Images for Y35

Lamotrigine extended-release 250 mg Y35

Lamotrigine Extended-Release

Imprint
Y35
Strength
250 mg
Color
Purple
Size
14.00 mm
Shape
Capsule/Oblong
Availability
Prescription only
Drug Class
Triazine anticonvulsants
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
Not a controlled drug
Labeler / Supplier
Yiling Pharmaceutical, Inc.
National Drug Code (NDC)
69117-0048

Get help with Imprint Code FAQs.

Related images for "Y35"

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.